Sipai Health Technology Co,

Sipai Health Technology Co, ROE

The Return on Equity (ROE) of Sipai Health Technology Co, (314.HK) as of Nov 21, 2026 is -26.41 %. In the previous year, Return on Equity (ROE) was -15.80 % — a change of 67.15% (lower).

ROE

-26.41 %

YoY

67.15%

Last updated:

In 2024, Sipai Health Technology Co,'s return on equity (ROE) was -26.41 %, a 67.15% increase from the -15.80 % ROE in the previous year.

The Sipai Health Technology Co, ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2020
58.04 CNY
Jan 1, 2021
68.89 CNY
Jan 1, 2022
-74.61 CNY
Jan 1, 2023
-15.80 CNY
Jan 1, 2024
-26.41 CNY
The Sipai Health Technology Co, ROE history
YEARROEYoY
-26.41 %+67.15%
-15.80 %-78.83%
-74.61 %-208.30%
68.89 %+18.70%
58.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sipai Health Technology Co, Stock analysis

What does Sipai Health Technology Co, do? Sipai Health Technology Co., Ltd. generates revenue through its Specialty Pharmacy Business, which operates offline specialty pharmacies and distributes pharmaceutical products to pharmaceutical companies and distributors. The Physician Research Assistance Business offers integrated services to pharmaceutical companies for producing clinical trial data that meets regulatory standards, supporting their progression to later clinical phases or regulatory approvals. The Health Insurance Services Business provides insurance brokerage services, distributing various health and life insurance products on behalf of insurance carriers. These segments collectively serve pharmaceutical companies, healthcare providers, and insurance carriers through specialized offerings in pharmacy distribution, clinical research support, and insurance brokerage. The company's Specialty Pharmacy Business focuses on offline pharmacy operations and pharmaceutical distribution, targeting pharmaceutical companies and distributors as key clients. Physician Research Assistance Business caters to pharmaceutical companies requiring regulatory-compliant clinical trial data for advancing drug development. Health Insurance Services Business partners with insurance carriers to distribute health and life insurance products to end customers, leveraging the company's brokerage platform for insurance product distribution. Sipai Health Technology's business model integrates pharmacy distribution, clinical research support, and insurance brokerage to address specific needs within the healthcare sector. The Specialty Pharmacy Business serves pharmaceutical companies and distributors with offline pharmacy networks and product distribution. Physician Research Assistance Business assists pharmaceutical companies in meeting regulatory requirements for clinical trials, while Health Insurance Services Business facilitates insurance product distribution through brokerage partnerships with carriers. Sipai Health Technology Co, is one of the most popular companies on Eulerpool.

ROE Details

Decoding Sipai Health Technology Co,'s Return on Equity (ROE)

Sipai Health Technology Co,'s Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Sipai Health Technology Co,'s ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Sipai Health Technology Co,'s ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Sipai Health Technology Co,’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Sipai Health Technology Co, stock

Return on Equity (ROE) of Sipai Health Technology Co, is -26.41 % in 2024.

Return on Equity (ROE) of Sipai Health Technology Co, changed from -15.80 % to -26.41 %, representing a 67.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Sipai Health Technology Co, since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Sipai Health Technology Co, with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Sipai Health Technology Co,

All Key Metrics — Sipai Health Technology Co,